SYN-004 Safety and Tolerability in Allo-HCT Subjects
SYN-004 Safety and Tolerability in Allo-HCT Subjects
Active, not recruiting · NCT04692181 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SYN-004 Safety and Tolerability in Allo-HCT Subjects | Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant; Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-17 | NCT04692181 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Theriva Biologics, Inc. | 1 |
| Washington University School of Medicine | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Washington University | St Louis | United States | 182 |